Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

50%

1 of 2 completed trials have results

Key Signals

1 recruiting1 with results

Enrollment Performance

Analytics

No phase data available

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT06808633Recruiting

Efficacy of Direct Selective Laser Trabeculoplasty in Clinical Practice in Patients with Glaucoma

Role: lead

NCT05392998Completed

Tolerance to Residual Astigmatism in Eyes With Vivity®

Role: lead

NCT05392738Unknown

Visual Function and Patient Satisfaction in Glaucoma or Ocular Hypertensive Patients Undergoing Simultaneous Cataract Surgery and i-Stent Implantation

Role: lead

NCT04916041Unknown

Visual Function in Subjects Implanted With Advanced Technology Intraocular Lenses

Role: lead

NCT03787576Completed

Evaluating Patient Satisfaction After Cataract Surgery With Multifocal Intraocular Lens

Role: lead

All 5 trials loaded